Baxter International Aktie

70.10 CHF -1.97CHF -2.74%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
The Vanguard Group, Inc. 7.19
Wellington Management Co. LLP 6.36
BlackRock Fund Advisors 5.06
SSgA Funds Management, Inc. 4.70
Third Point LLC 4.51
Fidelity Management & Research Co. 3.57
Morgan Stanley Investment Management Ltd. 2.93
Columbia Management Investment Advisers LLC 2.24
Northern Trust Investments, Inc.(Investment Management) 1.72
Norges Bank Investment Management 1.64
Veritas Asset Management LLP 1.55
State Farm Investment Management Corp. 1.34
The Caisse de dépôt et placement du Québec 1.26
Geode Capital Management LLC 1.24
Lazard Asset Management LLC 1.02

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018
Personal am Ende des Jahres 66'000 50'000 48'000 47'000 50'000
Umsatz pro Mitarbeiter in Mio. EUR 0.25 0.20 0.21 0.22 0.22

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018
Summe Umlaufvermögen 10'351 11'796 6'574 7'263 5'919
Summe Anlagevermögen 17'425 15'366 11'072 12'636 11'271
Summe Aktiva 25'917 20'975 15'546 17'111 15'641

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 9'305 6'520 2'782 3'512 3'477
Summe Fremdkapital 17'761 12'110 7'266 7'995 7'825
Summe Eigenkapital 8'156 8'865 8'280 9'116 7'816
Summe Passiva 25'917 20'975 15'546 17'111 15'641

Adresse

One Baxter Parkway, 60015-4625 Deerfield
Telefon 18479482000
Fax 18479483642
Internet http://www.baxter.com

Management

Albert P. L. Stroucken
Independent Director
Amy A. Wendell
Director
Brian C. Stevens
Chief Accounting Officer, SVP & Controller
Catherine R. Smith, MBA
Independent Director
Clare Trachtman
Vice President-Investor Relations
David Ferguson, PhD
General Manager-Medication Delivery
David Harrison Roman
Vice President-Strategy
Dennis Crowley
Senior VP-Business Development & Licensing
Ellen K. McIntosh
Secretary & Senior Vice President
Fang-Tyan Chen, MBA
Independent Director
Giuseppe Accogli
Senior Vice President & President-Americas
James K. Saccaro
Chief Financial Officer & Executive Vice President
James R. Gavin III, MD
Independent Director
Jeanne K. Mason, PhD
Vice President-Human Resources
John D. Forsyth
Independent Director
Jorge Vasseur
General Manager-Nutrition
José E. Almeida
Chairman, President & Chief Executive Officer
Kimberly A. White
Chief Communications Officer
Laura Angelini
General Manager-Chronic Renal
Michael F. Mahoney, MBA
Independent Director
Patricia B. Morrison
Director
Paul E. Martin
Chief Information Officer & Vice President
Peter S. Hellman, MBA
Lead Independent Director
Reaz Rasul
General Manager-Acute Therapies
Scott A. Bohaboy, MBA
Treasurer, Vice President & Head-Global Planning
Scott Pleau
Senior Vice President-Operations
Sean B. W. Martin
Senior Vice President & General Counsel
Stacey T. Eisen
Senior Vice President-Global Communications
Stephen N. Oesterle, MD
Independent Director
Sumant Ramachandra MD, PhD
Senior VP, Chief Science & Technology Officer
Thomas T. Stallkamp, MBA
Lead Independent Director
Wilber C. Boren
General Manager-Advanced Surgery

Eintrag hinzufügen